chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Discharge Provider: MD  Primary Care Physician at Discharge: DO Admission Date: 9/26/2023  Discharge Date: 10/5/2023 DETAILS OF HOSPITAL STAY: Acute respiratory failure (HCC) [J96.00] Respiratory failure, acute (HCC) [J96.00] Acute hypoxic respiratory failure (HCC) [J96.01]   HOSPITAL COURSE:   Patient is a 2 y.o. male with PMHx abnormal congenital neurologic findings, focal epilepsy, infantile spasm, G-tube dependence, and OSA who presented initially for acute hypoxemic respiratory failure secondary to Rhino-entero virus bronchiolitis and urinary tract infection. Patient developed cough and congestion. He is on 0.5L O2 at home during the night. His twin sister was also sick during this time. Dad stated his work of breathing increased and they came to the ED after trying his sick day regimen without relief.    In ED, Patient had a gas which showed pH 7.2, CO2 67, Bicarb 27. Trialed NIPPV which greatly improved work of breathing. Given dose of Vancomycin and Rocephin. Urinalysis demonstrated small blood, WBC more than 180 and no bacteria. CXR read as consistent with viral process, no focal consolidation. Patient was admitted for acute hypoxic respiratory failure.   In the PICU, he was weaned to HFNC <1L, on Xopenex q4h, Vest q4 hours and tolerated this regimen. He follows the ketogenic diet and works with the neuro nutritionist and following his sick day feeding plan (on step 3 of 4). He had a decrease in bowel movements and miralax was added on to relieve this issue. He was started on 14 days of Augmentin for his UTI, with good urine output. He continued on his seizure meds without seizures. He did develop a wound on the bridge of his nose.    He was admitted to the general pediatrics floor and weaned to RA (baseline 0.5L at night). He was tolerating his full feeds and remained hemodynamically stable. He was sent home to complete augmentin for UTI and completed his VCUG that showed no reflux.
Patient stated that two hours after vaccine blood pressure shot up and was seeing a visual aura. Sought treatment at ER was not sure if adverse event or a migraine.
My daughter recived the first HPV guardasil shot on 9-16-2008.  She received meningococcal vaccine at the same time. After the first shot she had a very unusual rash breaking out lasting for about 2 weeks.   I did not make the connection until after the 2nd HPV shot on 11-19-2008 when it happened again.  In addition this time she had severe neck and back pains severe stomach cramping dizey spells,and feeling weak.  It has been 2 months since the 2nd shot.  Her doctor has seen her still rash talked to her about her other symptoms that have for the most part cleared up.  My daughter will be getting a barage of blood work tomorrow.  She is a highly allergic child and had the CDC done a better job of educating parents on their pamplets I would have never never ever let my daughter get this shot. I do not believe children that are chemically sensitive dyes excetra should ever have this shot. To this day the CDC in their pamplet still says there are NO seriouse side effects.  2/24/09 MR received from PCP from 10/8/08 to 2/05/09. WCC 10/8/08 with normal exam. HPV#2 11/19/08. Returned 12/5/08 with c/o neck and back pain and URI sx. PE (+) for discomfort when palpating musculature of posterior neck along T-spine. Impression:  URI.  BSOM.  Neck and Back pain-suspect muscular.  Returned 1/9/09 with facial rash and intermittent R hip and leg pain, abdominal cramps on and off. PE (+) for mauculopapular rash face, chest & extremities. Impression:  Contact dermatitis. R leg pain now resolved. Vaccination reaction per hx. Returned 2/5/09 with c/o H/A, joint pain, neck soreness and cough. Imp:  viral syndrome.  sinusitis.  8/18/09 TC from parent to report pt now has dx: ezcema.
Tingling and numbness noted around mouth 5 minutes after vaccine administered. Pepcid administered 2 minutes after symptoms noted  and Zyrtec administered 20 minutes after symptoms noted. Patient waited a total time of 1 hour after vaccine administered and reported no increase or worsening in symptoms. Patient was instructed to go to the Emergency Department if symptoms worsen and to contact their primary care provider for follow up care.
Patient requested to receive a 2nd dose of Shingrix to a technician.  Pharmacist confirmed with the patient that she is going to receive a 2nd dose of new Shingles vaccine(Shingrix) and after receiving patient asked about coming for a next dose. So, after further talking to the patient and checking system,  it was found that patient was under the impression that she got Zostavax in 2019 and wanted to get Shingrix since Dr. told her to get the new Shingles vaccines. Basically, in 2019 patient completed 2 dose series of Shingrix and in March 2023 she ended up getting a 3rd dose of Shingrix. Patient was observed for 30 minutes and was informed about the situation as well.  Patient was feeling fine and had not reaction, hence was sent home.
Pts mom came into office stating that the evening p/pt recvd vax was hospitalized w/pneumonia & croup; mom stated MD indicated that this could be a poss reaction to DTP vax; rxn reported on 16OCT; pt irritable, crying, stridor, vomit, fever
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39-year-old male patient received BNT162b2 (BNT162B2), on 09Mar2021 as dose 1, single (Lot number: EN6202), in right arm, on 31Mar2021 as dose 2, single (Lot number: EN6955), in right arm and on 06Nov2021 as dose 3 (booster), single (Lot number: FH8020) at the age of 38 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Sulfa" (unspecified if ongoing). The patient took unspecified concomitant medication in 2 weeks of vaccination. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown Results, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical Course: The patient was treated with anti-viral drug Paxlovid (Treatment of COVID-19) which was started on 30Jun2022 (Lot no: GA8849).
Sleepiness and discomfort on the same day. Next day in the afternoon chill and on the third day cellulitis on the arm where they applied the dose.
Two weeks after the flu shot, started having generalized mycloinc seizures and generalized convulsive seizures.  Three different anticonvulsants were tried, then IVIg was given to the patient. She is still having seizures not as many, but she must wear a helmet all the time. We are down to less than 5 a day. 3/31/2010 Follow up: The seizures stopped, but it is hard to tell if she has any mental deficis at this time.
COVID/Caller also mentioned he has had 2 COVID vaccines from Pfizer, and probably one booster dose also from Pfizer.; COVID/Caller also mentioned he has had 2 COVID vaccines from Pfizer, and probably one booster dose also from Pfizer.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID/Caller also mentioned he has had 2 COVID vaccines from Pfizer, and probably one booster dose also from Pfizer.". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19 and taken Paxlovid  as a treatment.  Clinical Information; when consumer requested for further details; was reported that Paxlovid consists of Nirmatrelvir and Ritonavir. Working together, these medications prevent the viral replication. The medical objective of Paxlovid is to stop the progression of COVID-19 into a severe infection that would require hospitalization or major cares.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Pt was hospitalized Feb 610 with pulmonary emboli in both lungs and both legs. Day after hospital discharge, he received first dose of Moderna COVID-19 vaccine (no noticeable side effects); was recovering slowly with home health services (PT, OT, Skilled Nursing) when he received second Moderna shot Mar 11. On Mar 12 he was prostrate with fever (103.5°) and chills, unable to get out of bed for several days, weakened considerably, to a greater extent than after hospital discharge. He had a 2nd reaction Mar 19 (fever, chills, and prostration); was admitted to a rehab facility where he remained for two weeks. He was discharged from rehab on Apr 3 & is recovering at home with PT.
Shortness of breath ness; need deep breath; squeezing chest pain almost every hour, waking up in the middle of the night every hour with pain.
4 cm X 4 cm spread erythema, tender to touch, hot, swollen at the site of injection.  Symptoms appeared 3 days after injection.
Patient was given 0.5ml dose, instead of 0.25ml booster dose.
Pt recvd vax 14FEB86 & tested pos for Anti-HBs (lab results were neg for anti-HBs on 10JUL85); pt donated blood in 1990 w/no noted problems; tested pos for hep B core antibody; lab eval on 17JUl92 revealed neg anti-HBs of 1.3 HBe-AG, neg
Mild to moderate headaches, chills and flush feeling  Ibuprofen 600 mg @ 2 times/day
Moderna 3/3/21, 3/31/21, 11/17/21
Patient reported symptoms of pain and a rash that went down her arm. The rash was red and bumps. It started that night after the vaccine and lasted 3-4 days until it started to get better.
Patient is a 32 yo female with past medical histry of POTS. She received her 1 dose of pfizer vaccine and about 10 minutes later began to experience lightheadedness and headache. She reports being unsteady on feet. She was transfered via wheelchair to first aid bay. Vitals as follows: BP 106/70, HR 83, 98% on room air. She was given water and gatorade and lay in cot for additional 15-20 mins. Her symptoms completely resolved and she ok to leave. Her husband had dropped her off and drove her home.
Mother states child developed Temp 103.8 within 24 hours of vaccine administration with prolonged crying.  Did not seen medical TR.  Advised physician prior to next set of vaccines.
Numbness of lips and throat commencing approximately one hour after receiving vaccine. Patient self-treated with benadryl and symptoms resolved after about 2 hours.
Slight swelling of toes (first on right foot and ca. one week later of a couple on left foot) accompanied by blotchy appearance and tenderness and inflammation. Blistering sort of phenomenon (although no open sores). Looks the same as what I see on internet as "COVID-toes", although I've not seen any sign of it as a reaction to the vaccine itself.
Stuffy nose; This is a spontaneous report from a contactable consumer (patient) reported for himself. A male patient of an unspecified age received bnt162b2 (mRNA, Solution for injection, Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 1, single, then via an unspecified route of administration on an unspecified date as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that consumer reports speaking person, who caller asked if they were fighting a cold, the person reported still having a stuffy nose ever since receiving both Pfizer vaccinations two months ago. Treatment was reported as nothing in addition to concomitant medications. The outcome of event was not resolved.  Information on Batch/Lot number has been requested.
Had hives w/in 1 hrs of having vax needed epi & steroids 3 time w/4 visits to the hosp; pt is still taking DPh;
shortness of breath; irritable bowel; tingling everywhere; Gas; floating; inflammation; chest pain; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), IRRITABLE BOWEL SYNDROME (irritable bowel), PARAESTHESIA (tingling everywhere), FLATULENCE (Gas) and FEELING ABNORMAL (floating) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (shortness of breath), IRRITABLE BOWEL SYNDROME (irritable bowel), PARAESTHESIA (tingling everywhere), FLATULENCE (Gas), FEELING ABNORMAL (floating), INFLAMMATION (inflammation) and CHEST PAIN (chest pain). At the time of the report, DYSPNOEA (shortness of breath), IRRITABLE BOWEL SYNDROME (irritable bowel), PARAESTHESIA (tingling everywhere), FLATULENCE (Gas), FEELING ABNORMAL (floating), INFLAMMATION (inflammation) and CHEST PAIN (chest pain) outcome was unknown.            Concomitant medication use was unknown Treatment information was unknown   This case was linked to MOD-2021-017731 (Patient Link).
This individual is now deceased due to a myocardial infarction secondary to a thrombus.  He was alone at the time of the event, therefore no immediate details are known.  His family reported that the 2 days prior, they were all hiking  and he had no problems.   He is suspected to have actually died on 03/20/2021; however, it took some time to find him, therefore the autopsy indicates date of death to be 03/21/2021 due to that's when he was located, already deceased.
Headache then teeth chattering chills lasting about 2 hrs.  Patient couldn't get warm even with electric mattress pad set at 5 the highest number and additional blankets.
Pt recv vax on 3/9/99; on 3/14/99 pt exp fever, fussy, crying, rash on trunk
Developed diffuse severe urticarial rash 6 days after vaccine. Had skin testing to egg and peanut on 2/20/19 which was normal. Allergist feels it is a serum sickness rash to flu vaccine
Hours after vaccination developed pain and swelling of upper arm that caused extreme pain, developed weakness of right arm. Pain extending up neck, into chest and down forearm. Small area of erythema and induration.
Pt had a positive COVID test on 12/29/21; pt was in the hosp and dc'd to home on 12/20/21 with gastroenteritis, COVID, AKI; presents back to hosp on 1/4/22 with c/o fever and chills; worsening hypoxia; O2 supplementation; chest x-ray shows COVID pneumonia; given "COVID directed therapies"; worsening PNA  and delerium; pt is now a DNR/DNI; dc'd to home with a Hospice on 1/13/22; presuming pt died at home on 1/15/22; do not have access to death certificate; med records sent to info@vaers.org
I contacted the CDC and was informed of this vaccination of Kinrix,  that Kinrix can only be used on patients who have been / are on time for their vaccines. Anyone who is on a catch up schedule should not be considered for kinrix. I called to see what would be the best way to go about this and their recommendations. They are only approved for the 5th dose of Dtap and the 4th dose of Polio. So the last dose.  This dose will be counted without error per CDC recommendations.  Pt did NOT have a reaction, this was a immunization error with a multidose given and not each individually
The patient received catch up vaccines (MMR & Var) on 4-13-12. She developed few lesions on 4-19-12 and was seen on 4-20-12 in the office and Dxed with viral exanthem (suspected Varicella). Developed high fever on 4-21-12 and facial swelling on 4-22-12 and seen at clinic on 4-22-12. Seen in office on 4-23-12 and dxed with Bell's Palsy. Referred to Neurologist. Pt. clinically well.
Localized swelling approximately 5" from injection site (bicep area) and to include fever in area.
Mother reports infant had a 20 second seizure 2 days after vaccines were administered. Was taken to private physician for evaluation. No other action taken. Temperature 99.0 per mom.
Six days following the Janssen covid vaccine, all of my joints started popping and burning. All my muscles became tight and painful to the point that I could not walk or rise from sitting. I have been diagnosed with POTS, postural orthostatic tachycardia syndrome.  My neck became painful with cervical instability and nerve pain.  I have suffered POTS symptoms of high heart rate/ low blood pressure, balance issues, skin problems, GI tract pain, pelvic pain, lower back pain, tinnitus as well as calf/ankle/foot/wrist pain. My vision was at times is blurry with spots and double vision. I am not able to take care of myself, and walk with a walker.
Severe headaches after H1N1 vaccine nasal mist was administered 17 days after seasonal flu vaccine nasal mist was administered.  Nurse assured parent that administering H1N1 mist less than 28 days after seasonal flu mist would not be harmful, but might be less effective than waiting the full 28 days between vaccines.  Several doctor visits to patient's regular pediatric practice resulted in medicating with allergy medications (Nasonex, Neti Pot and Zyrtec) which did not alleviate crushing headache pain.  Tried full 10 day dose of Augmentin antibiotics in case sinus infection might be cause.  This also did nothing to alleviate headaches.  Adult strength doses of Motrin, Tylenol and Excedrin ineffective.
04/19/2021 arm, fingers and right arm was swollen 05/2/2021 knee was swollen
I was very lethargic, warm (without a fever), and very achy. This lasted until I went to bed at 9pm and I felt fine when I woke up the next day. I took no medication for this nor did I seek medical treatment.
Trouble breathing, throat closing, dry mouth, body aches, chills, temp 100.0, headache. Took BENADRYL 4 tsp. Breathing was better after 20 mins. Went to bed. Felt better in the morning. Very tired next day. Stay in bed until 5pm. Slow got back to normal.
Initial information received on 21-Nov-2018 regarding an unsolicited valid non-serious case received from a nurse. This case involves a 75 years old male patient who was vaccinated with a 0.5 ml dose of vaccine FLUZONE HIGH DOSE (lot number UI9811AB or UJ9811AB and Exp. Date 16 March 2019) via intramuscular route in the left deltoid on 05-Nov-2018. And that vaccine experienced temperature excursion for 3 hours at (-3) degrees Celsius. The patient's medical history and concomitant medications were not reported. It was an actual medication error due to incorrect product storage. It was unknown whether the patient experienced any adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender: none.
Dose #2 of Pfizer Lot # EN5318  1/29/21 @ 1115   Pt reported tongue numbness a few minutes after Pfizer COVID vax#2 was administered. She denies SOB, wheezing, rash or other concerning symptoms.. VSS. Diminished somewhat only to return about 5 min later accompanied with dizziness. MD of Day Dr contacted and recommended Pt be transported via Urgent Care for further evaluation, monitoring and treatment
It was reported in a published article, title as stated above that a 4.6 month old patient who was born prematurely, had a total vaccination failure and developed invasive Hib disease, also referred to as meningitis, only 11 days after receipt of a second dose of PedvaxHib (manufacturer unknown) at 1.5 months of age. No further information was available at the time of this report. No outcome information was reported. Upon internal review, invasive Hib disease/meningitis has been determined to be an other important medical event. Additional information has been requested.
This spontaneous report as received from a physician refers to a patient of unknown age and gender. On an unknown date the patient was vaccinated with the first dose of GARDASIL (strength, route, lot number and expiration date not reported). The physician stated that the patient fainted at an unspecified time afterwards. At the time of the report the outcome of the event was unknown. Additional information has been requested.
Patient was incorrectly given hepatitis B instead of Hib in addition to PEDIARIX and PREVNAR.
Seizure. Convulsions, lost consciousness, amnesia, high blood pressure, confusion. Numbness of lower lip, tingling in hands and feet, consistent headache, fatigue, memory problems, and filling out of my body  are all still occurring five days later.
Came in today 09/07/2018 over a duration of 7 days: itching, redness & swelling at/around the injection site the size of an orange *painful to the touch starting the almost two days after and lasted for 5 days. Has not seen her physician but nurse from where she gets her allergy shots recommended she talk to her doctor or pharmacist.
After receiving my third dose of Moderna vaccine for Covid-19, my IGa Nephropathy flared up within hours of receiving the shot - and my proteinuria numbers rose to higher ranges than it has ever been. My urine protein/creatinine output rose above 7000 mg/g. Normal range is under 200 mg/g, and my average has remained at 500mg/g regularly. I began to see blood in my urine, beginning on 1/22/22.  To date, my urine protein/creatinine output remains above 3000 mg/g.  I have been taking Budesonide EC for treatment.
Patient was supposed to receive MMR vaccine and was given varicella in error.  Pt is aware and no adverse reaction occurred.
Patient received a 3rd dose of pfizer COVID-19 vaccine (the 5-11 yr dose) approximately 4 weeks after completing the 2 dose primary series.  No adverse reaction occurred as of this writing but per instructions from CDC an erroneous administration of COVID vaccine is to be reported to VAERS.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. Medical history, concurrent conditions, and concomitant medications were not provided. On or about 10-OCT-2015, at a pharmacy, the patient was inoculated with ZOSTAVAX, (by an unspecified healthcare professional) as recommended for routine adult health maintenance and for the prevention of shingles (dose, route of administration, site of administration and lot # were not provided). The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 21-JUN-2016, the patient was treated by a physician/MD (at an unspecified facility) for the onset of a severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as herpes zoster, or shingles. The patient was subsequently treated by the same physician/MD for ongoing and worsening outbreaks of shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was not recovered. The lawyer felt the events were related to ZOSTAVAX. Additional information has been requested.